Navigation Links
MiRNA-21 linked to tumor suppressor loss, herceptin resistance
Date:4/19/2010

WASHINGTON, D.C. - Overexpression of a specific type of microRNA can derail treatment by disabling an important molecular brake on breast cancer cell proliferation, according to evidence presented by researchers from The University of Texas M. D. Anderson Cancer Center at the American Association for Cancer Research 101st Annual Meeting 2010.

The study showed that MiRNA-21 interferes with trastuzumab (Herceptin) therapy by blocking the phosphates and tensing homolog gene known as PTEN.

"PTEN acts as a tumor suppressor and is involved in regulating cell proliferation and death," said Sumaiyah K. Rehman, first author of the study and a graduate research assistant in the Department of Molecular and Cellular Oncology at M. D. Anderson. "When it is expressed normally, cells proliferate more slowly and senesce, or stop growing."

Mutations in the PTEN gene play a role in many types of cancer and influence both the development of breast cancers and their response to treatment.

"We know that there are signaling pathways in cancer cells that drive malignancy and progression," said senior author Dihua Yu, M.D., Ph.D., professor and deputy chair of the Department of Molecular and Cellular Oncology. "PTEN acts as a brake on those monogenic signaling pathways, and PTEN loss has been found in about 40 percent of breast cancers. So it is well-documented that PTEN loss is correlated with a poor clinical outcome in breast cancer patients."

Interfering with a targeted therapy

MicroRNAs (MiRNA) are snippets of RNA that influence gene expression by targeting specific messenger RNAs (mRNA). mRNAs are responsible for ensuring that proteins and their products are produced correctly, and interference from miRNAs can disrupt or alter this normal protein production.

"MiRNAs are molecules that exist in our cells and regulate a variety of physiological functions," said Rehman, who also is a graduate student at The University of Texas Graduate School of Biomedical Sciences at Houston (GSBS). "MiRNA regulation is disrupted in most diseases and in all cancers." Altered expression of miRNA also has been linked to the development of resistance to chemotherapy drugs such as cisplatin.

The researchers suspected that overexpression of miRNA-21 leads to reduced levels of PTEN and, in turn, to resistance to Herceptin. Herceptin is a targeted therapy used to treat metastatic breast cancer. Like other targeted cancer treatments, Herceptin homes in on a specific abnormal gene to slow or shut down cancer growth. The target gene in Herceptin treatment is ErbB-2-also known as HER2/neu or HER2.

"Herceptin is the most successful example of targeted cancer therapy," Yu noted. "But only about one-third of patients benefit from this therapy as a single agent." PTEN loss is a key reason.

MiRNA-21's role in Herceptin resistance

The hypothesis was tested in three HER2-overexpressing breast cancer cell lines. In a series of experiments, miRNA-21 and/or a control miRNA were introduced and expressed in the HER2-overexpressing cell lines. The cells were then treated with Herceptin. The researchers found that cells with higher levels of miRNA-21 had reduced PTEN expression and were significantly more resistant to the drug than were the control cells.

The researchers also determined that miRNA-21 reduces PTEN expression by inhibiting PTEN messenger RNA at a specific site in the PTEN transcript in breast cancer cells.

In another experiment, when the researchers downregulated miRNA-21 in high HER2-expressing cells, cellular PTEN levels rose, and the cells became more sensitive to Herceptin compared to control miRNA cells.

The researchers then sought to determine the clinical relevance of their findings by measuring levels of miRNA-21 in tumor samples from patients with HER2-positive breast cancer treated with Herceptin. They found a significant correlation between high levels of miRNA-21 and poor patient response to Herceptin, as well as a correlation between elevated miRNA-21 and disease progression.

Rehman also observed that patients with low tumor levels of miRNA-21 tend to experience either a partial response to Herceptin or stable disease.


'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-516-4855
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Related medicine news :

1. Abnormal Heart Rhythm Linked to Alzheimers
2. Human development index linked to stem cell transplant rates and success in leukemia patients
3. Temperature-sensing protein linked to skin cancer, hirsutism
4. Better patient safety linked to fewer medical malpractice claims in California
5. Age Management Medicine Conference Reports 21% Spike in Physician Registration, Linked To Frustrations With New Health Reform Legislation
6. Scientists find gene linked to schizophrenia
7. Vitamins C, E Wont Cut Risk of Pregnancy-Linked Hypertension
8. Fetal alcohol spectrum disorder linked to high prevalence of epilepsy, Queens study
9. Unvaccinated Boys at Risk of Mumps-Linked Testicular Problem
10. Parkinsons Linked to Genetic Mutation
11. Sleep Apnea Linked to Eyelid Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... ... , ... An inventor and manicurist from Greet, S.C., wants to offer people a new way ... maintain clean and healthy feet, so I know the importance of proper foot care," he ... designed the FOOT-TRAN SYSTEM." , The FOOT-TRAN SYSTEM enables a user to clean and exfoliate ...
(Date:3/30/2017)... ... March 30, 2017 , ... This ... to President Trump expressing their support for an independent Vaccine Safety Commission. Five ... and one medical journalist, will hold a press conference at 9:00 AM ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... In the ... to 300,000 people each year develop other types of metastatic brain tumors(3). Though most ... the brain(3). As efforts focus on finding more effective treatment options, the San ...
(Date:3/29/2017)... ... ... the main cause of hay fever in the United States, with an estimated 95 percent ... to July each year; with the worst time for sufferers being June and July. ... ) provide an effective defense against grass pollen; they are proven in independent studies to ...
(Date:3/29/2017)... St. Petersburg, FL (PRWEB) , ... March 30, 2017 , ... ... Often called the "Spice of Life" or "Wonder Spice", it has been used for ... extensive use in the East," says Heshelow, author of " Turmeric: How to Use ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 29, 2017 Research and Markets has announced the ... Treated at Proton Therapy Centers & Forecast" report to their offering. ... The South Korean Proton ... market size in 2016. The Untapped Proton Therapy Market for ... in 2016. Proton Therapy plays an important role in ...
(Date:3/29/2017)... , March 29, 2017  Experts in the ... monitoring devices like  Soberlink Systems  as a model ... paper, published in early 2017, concluded that remote ... in managing patient recovery." The findings ... of Addiction Medicine, detail a range of variables ...
(Date:3/29/2017)... Calif. , March 29, 2017 ... for patients as the highest standard in quality ... Krypton Vision introduces its objective Wavefront-driven refraction technologies ... subjective approach. This enables an unprecedented level of ... - exceptional vision relegated to Topgun Navy fighter ...
Breaking Medicine Technology: